Top Page
Versarien
(LSE:VRS)
Versarien (VRS) vs. S&P 500 (SPY)
Versarien Business Overview & Revenue Model
Versarien Financial Statement Overview
| Breakdown | ||||
| Sep 2024 | Sep 2023 | Sep 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 2.42M | 5.45M | 7.40M | 7.63M | 6.57M | Gross Profit |
| -468.00K | -248.00K | 800.00K | 2.45M | 1.46M | EBIT |
| -3.19M | -4.83M | -4.04M | -4.74M | -7.91M | EBITDA |
| -2.66M | -12.29M | -3.67M | -3.30M | -6.76M | Net Income Common Stockholders |
| -4.12M | -13.53M | -5.38M | -5.08M | -7.78M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 145.00K | 596.00K | 1.35M | 3.10M | 2.36M | Total Assets |
| 6.64M | 10.38M | 22.20M | 23.84M | 25.24M | Total Debt |
| 5.99M | 7.31M | 7.97M | 5.57M | 3.59M | Net Debt |
| 5.84M | 6.72M | 6.62M | 2.47M | 1.24M | Total Liabilities |
| 7.79M | 9.30M | 10.36M | 9.40M | 8.75M | Stockholders Equity |
| 824.00K | 3.19M | 13.22M | 15.84M | 17.78M |
| Cash Flow | Free Cash Flow | |||
| -1.75M | -3.08M | -8.34M | -5.72M | -2.57M | Operating Cash Flow |
| -1.72M | -2.74M | -3.68M | -2.15M | -894.00K | Investing Cash Flow |
| 198.00K | -336.00K | -4.66M | -3.57M | -1.68M | Financing Cash Flow |
| 1.07M | 2.32M | 7.33M | 6.46M | 3.28M |
Versarien Technical Analysis
Versarien Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | £5.42M | ― | -33.20% | ― | -13.98% | -6.84% | |
49 Neutral | $1.97B | -1.18 | -21.24% | 3.71% | 1.29% | -31.16% | |
48 Neutral | £1.96M | ― | -198.56% | ― | -55.51% | 93.81% | |
46 Neutral | £4.81M | ― | -92.35% | ― | -27.64% | ― | |
31 Underperform | £10.62M | ― | ― | ― | -149.21% |
Versarien Corporate Events
Versarien plc announced that all resolutions were passed at its recent Annual General Meeting. The resolutions included receiving the directors’ report and audited financial statements, re-appointing BDO LLP as the independent auditor, and re-appointing Susan Bowen as a director. This successful AGM reflects the company’s stable governance and continued focus on strategic objectives, potentially reinforcing stakeholder confidence.
Versarien Plc reported its audited results for the year ended 30 September 2024, highlighting a decrease in group revenues to £2.4 million and a reduced loss before tax of £4.3 million. The company has made significant strides in commercializing its technologies, including successful trials of its Cementene™ product, partnerships for 3D construction printing, and strategic contracts in the energy sector. Despite financial challenges, Versarien is actively seeking additional equity funding to ensure operational continuity, while continuing to expand its market presence and technological advancements.
Versarien plc announced that all resolutions were passed at its recent General Meeting, allowing the company to allot up to 2,991,220,000 new Ordinary Shares. This decision, supported by a significant majority of votes, grants the directors authority to disapply statutory pre-emption rights, potentially impacting the company’s capital structure and market positioning.
Versarien Plc has signed a two-year supply agreement with Montana Química to provide its proprietary Graphinks™ products, enhancing their existing partnership. This agreement, alongside a royalty arrangement, strengthens Versarien’s position in the advanced materials sector and expands its market presence in construction, composites, coatings, and lubricants.
Versarien PLC has announced a General Meeting scheduled for March 24, 2025, to seek shareholder approval for renewing its share capital authorities. This renewal is crucial for the company to maintain operational flexibility and secure strategic investments, which are vital for its ongoing financial stability and growth. The company is in advanced discussions with a third party for a potential strategic investment, and the renewal of share capital authorities is necessary to complete this transaction. The company has made significant progress in reducing annual losses and increasing graphene revenues, positioning itself for future profitability.
Versarien plc has completed the sale of its Korean plant and equipment to MCK Tech Co. Ltd, receiving a total of £611,000 including interest. This move aligns with Versarien’s strategy to monetize intellectual property through licensing, granting MCK Tech an exclusive license to use five of its patents in Korea, with potential revenue implications based on sales performance.
Versarien plc has announced its total voting rights, with an issued share capital consisting of 4,464,508,521 Ordinary Shares, each with full voting rights. This figure is significant for shareholders as it determines their notification requirements under the Financial Conduct Authority’s rules, impacting how they manage their interests in the company.
Versarien plc has announced its total voting rights, with the company’s issued share capital consisting of 4,464,508,521 Ordinary Shares. This figure is significant for shareholders as it serves as the denominator for calculating changes in their interests under the Financial Conduct Authority’s rules, impacting how they manage their stakes in the company.
Versarien plc has announced a further deferment of capital repayments on a £5 million loan from Innovate UK, now set to commence in August 2026. This extension is intended to support Versarien’s turnaround strategy and ongoing efforts to commercialize its advanced materials, providing the company with flexibility to achieve key milestones and position itself for sustainable growth.